LONDON, April 3, 2018 /PRNewswire/ --
Stefano A Gandolfi, European Ophthalmic Review, 2017;11(2):103-7; https://doi.org/10.17925/EOR.2017.11.02.103.
(Logo: http://mma.prnewswire.com/media/515766/Touch_Medical_Logo.jpg )
Published recently in European Ophthalmic Review, the peer-reviewed journal from touchOPHTHALMOLOGY, Gandolfi discusses the fixed combination of brinzolamide
The full peer-reviewed, open-access article is available here:
Disclosure: Stefano A Gandolfi has nothing to declare in relation to this article. The publication of this article was supported by Novartis/Alcon Europe. The views and opinions expressed in the article are those of the authors and not necessarily those of Novartis/Alcon Europe.
touchOPHTHALMOLOGY (a division of Touch Medical Media) publishes the European Ophthalmic Review, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of ophthalmology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
"Touch Medical Media is a trading name of Touch Digital Media Limited, a private limited company registered in England and Wales at The White House Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142".
For inquires please contact: Nicola Cartridge - Editorial Director firstname.lastname@example.org +44-(0)-207-193-3186
"Leading the Debate on the Advances in Healthcare"
Subscribe to our Free Newsletters!